High materiality7/10
BridgeBio Oncology price target lowered to $15 from $23 at Stifel
Why it may matterVerify against the original reporting
bearish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Stifel Nicolaus lowers BBOT target to $15 from $23; current price around $8.86. Indicates bearish revision in near-term sentiment.
- Target downgraded to $15 from $23 by Stifel; current price $8.86.
Key facts
- 01
Target: $15
- 02
Posted price: $8.86
- 03
Analyst firm: Stifel Nicolaus
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.